ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 140 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q2 2021. The put-call ratio across all filers is 1.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $671,000 | -19.5% | 45,300 | -14.5% | 0.03% | -15.8% |
| Q2 2022 | $834,000 | -41.6% | 53,000 | 0.0% | 0.04% | -28.3% |
| Q1 2022 | $1,429,000 | -19.5% | 53,000 | +10.4% | 0.05% | -15.9% |
| Q4 2021 | $1,776,000 | -22.5% | 48,000 | 0.0% | 0.06% | -30.0% |
| Q3 2021 | $2,293,000 | +78.3% | 48,000 | +26.3% | 0.09% | +83.7% |
| Q2 2021 | $1,286,000 | +3.1% | 38,000 | +25.8% | 0.05% | +14.0% |
| Q1 2021 | $1,247,000 | – | 30,200 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DFPG INVESTMENTS, LLC | 456,390 | $5,541,000 | 3.62% |
| DAFNA Capital Management LLC | 173,914 | $1,890,000 | 0.65% |
| One68 Global Capital, LLC | 19,861 | $216,000 | 0.47% |
| Diametric Capital, LP | 51,982 | $565,000 | 0.41% |
| ARK Investment Management | 1,383,756 | $15,041,000 | 0.38% |
| EAM Investors, LLC | 52,833 | $574,000 | 0.13% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 31,404 | $341,000 | 0.05% |
| Nikko Asset Management Americas, Inc. | 280,548 | $3,050,000 | 0.05% |
| MGO ONE SEVEN LLC | 14,900 | $161,000 | 0.04% |
| Qube Research & Technologies Ltd | 67,702 | $736,000 | 0.02% |